PURPOSE: Higher pathologic grade, suboptimal debulking surgery, and late-stage are markers of more aggressive and advanced ovarian cancer. Neighborhood socioeconomic status (SES) has been associated with more aggressive and advanced tumors for other cancer sites, and this may also be true for ovarian cancer. METHODS: We examined the association between neighborhood SES and ovarian cancer tumor characteristics using data on 581 women diagnosed with epithelial ovarian cancer in Cook County, Illinois. Two complementary measures (concentrated disadvantage and concentrated affluence) were used to estimate neighborhood SES. Prevalence differences and 95 % confidence intervals were estimated in logistic regression models adjusted for age and race. RESULTS: Greater disadvantage was associated with higher grade tumors (p = 0.03) and suboptimal debulking (p = 0.05) and marginally associated with later tumor stage (p = 0.20). Greater affluence was inversely associated with stage at diagnosis (p = 0.004) and suboptimal debulking (p = 0.03) and (marginally) with tumor grade (p = 0.21). CONCLUSION: Our findings suggest that lower SES, estimated by neighborhood SES, is associated with ovarian cancer tumor characteristics indicative of more advanced and aggressive disease.
PURPOSE: Higher pathologic grade, suboptimal debulking surgery, and late-stage are markers of more aggressive and advanced ovarian cancer. Neighborhood socioeconomic status (SES) has been associated with more aggressive and advanced tumors for other cancer sites, and this may also be true for ovarian cancer. METHODS: We examined the association between neighborhood SES and ovarian cancer tumor characteristics using data on 581 women diagnosed with epithelial ovarian cancer in Cook County, Illinois. Two complementary measures (concentrated disadvantage and concentrated affluence) were used to estimate neighborhood SES. Prevalence differences and 95 % confidence intervals were estimated in logistic regression models adjusted for age and race. RESULTS: Greater disadvantage was associated with higher grade tumors (p = 0.03) and suboptimal debulking (p = 0.05) and marginally associated with later tumor stage (p = 0.20). Greater affluence was inversely associated with stage at diagnosis (p = 0.004) and suboptimal debulking (p = 0.03) and (marginally) with tumor grade (p = 0.21). CONCLUSION: Our findings suggest that lower SES, estimated by neighborhood SES, is associated with ovarian cancer tumor characteristics indicative of more advanced and aggressive disease.
Authors: Joellen M Schildkraut; Lauren C Peres; Traci N Bethea; Fabian Camacho; Deanna Chyn; Emily K Cloyd; Elisa V Bandera; Alicia Beeghly-Fadiel; Loren Lipworth; Charlotte E Joslin; Faith G Davis; Patricia G Moorman; Evan Myers; Heather M Ochs-Balcom; Veronica Wendy Setiawan; Malcolm C Pike; Anna H Wu; Lynn Rosenberg Journal: Cancer Causes Control Date: 2019-06-24 Impact factor: 2.506
Authors: Anthony J Alberg; Patricia G Moorman; Sydnee Crankshaw; Frances Wang; Elisa V Bandera; Jill S Barnholtz-Sloan; Melissa Bondy; Kathleen B Cartmell; Michelle L Cote; Marvella E Ford; Ellen Funkhouser; Linda E Kelemen; Edward S Peters; Ann G Schwartz; Katherine Regan Sterba; Paul Terry; Kristin Wallace; Joellen M Schildkraut Journal: Am J Epidemiol Date: 2016-08-03 Impact factor: 4.897
Authors: Tomi F Akinyemiju; Gurudatta Naik; Kemi Ogunsina; Daniel T Dibaba; Neomi Vin-Raviv Journal: Cancer Causes Control Date: 2018-02-10 Impact factor: 2.506
Authors: Katherine C Brewer; Caryn E Peterson; Faith G Davis; Kent Hoskins; Heather Pauls; Charlotte E Joslin Journal: Ann Epidemiol Date: 2015-04-18 Impact factor: 3.797
Authors: Holly R Harris; Kristin A Guertin; Tareq F Camacho; Courtney E Johnson; Anna H Wu; Patricia G Moorman; Evan Myers; Traci N Bethea; Elisa V Bandera; Charlotte E Joslin; Heather M Ochs-Balcom; Lauren C Peres; Will T Rosenow; Veronica W Setiawan; Alicia Beeghly-Fadiel; Lauren F Dempsey; Lynn Rosenberg; Joellen M Schildkraut Journal: Int J Cancer Date: 2022-06-30 Impact factor: 7.316
Authors: Charlotte E Joslin; Katherine C Brewer; Faith G Davis; Kent Hoskins; Caryn E Peterson; Heather A Pauls Journal: Gynecol Oncol Date: 2014-08-28 Impact factor: 5.482
Authors: Lauren C Peres; Traci N Bethea; Tareq F Camacho; Elisa V Bandera; Alicia Beeghly-Fadiel; Deanna L Chyn; Holly R Harris; Charlotte E Joslin; Patricia G Moorman; Evan Myers; Heather M Ochs-Balcom; Will Rosenow; V Wendy Setiawan; Anna H Wu; Lynn Rosenberg; Joellen M Schildkraut Journal: J Natl Cancer Inst Date: 2021-06-01 Impact factor: 13.506
Authors: Qiwei Yu; Liqiang Zhang; Kun Hou; Jingwen Li; Suhong Liu; Ke Huang; Yang Cheng Journal: Int J Environ Res Public Health Date: 2021-05-18 Impact factor: 3.390
Authors: Chloe Karpinskyj; Matthew Burnell; Arturo Gonzalez-Izquierdo; Andy Ryan; Jatinderpal Kalsi; Ian Jacobs; Max Parmar; Usha Menon; Aleksandra Gentry-Maharaj Journal: Diagnostics (Basel) Date: 2020-02-07